In summary, in multiple large-scale autopsy-confirmed studies we have demonstrated the diagnostic utility of CSF t-tau, p-tau, and Aβ1−42 in differentiation of AD and FTLD (Bian et al., 2008; Irwin et al., 2012b; Toledo et al., 2012). This evidence concerns the gene MAPT and Alzheimer disease.